Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Henry Clement Pitot

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 6 November 2026

Matched on OpenAlex author ID A5111498614. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 1

  1. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.11.011↗

Trials 1

  1. Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Principal investigator NCT01010126↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wilma Lingle · 1 shared paper, 2020 · strength 0.08
  2. Mitesh J. Borad · 1 shared paper, 2020 · strength 0.08
  3. Thomas C. Smyrk · 1 shared paper, 2020 · strength 0.08
  4. Ezequiel J. Tolosa · 1 shared paper, 2020 · strength 0.08
  5. Aminah Jatoi · 1 shared paper, 2020 · strength 0.08
  6. Angela L. McCleary‐Wheeler · 1 shared paper, 2020 · strength 0.08
  7. Axel F. Grothey · 1 shared paper, 2020 · strength 0.08
  8. Julian R. Molina · 1 shared paper, 2020 · strength 0.08
  9. Ryan Michael Carr · 1 shared paper, 2020 · strength 0.08
  10. Charles Erlichman · 1 shared paper, 2020 · strength 0.08
  11. George P. Kim · 1 shared paper, 2020 · strength 0.08
  12. Mien‐Chie Hung · 1 shared paper, 2020 · strength 0.08
  13. Tanios Bekaii‐Saab · 1 shared paper, 2020 · strength 0.08
  14. Robert R. McWilliams · 1 shared paper, 2020 · strength 0.08
  15. Martín E. Fernández-Zapico · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.